Phosphoproteomics toolbox: Computational biology, protein chemistry and mass spectrometry  by Hjerrild, Majbrit & Gammeltoft, Steen
FEBS Letters 580 (2006) 4764–4770Minireview
Phosphoproteomics toolbox: Computational biology, protein
chemistry and mass spectrometry
Majbrit Hjerrild*, Steen Gammeltoft
Department of Clinical Biochemistry, Glostrup Hospital, Nordre Ringvej, DK-2600 Glostrup, Denmark
Received 1 June 2006; revised 21 July 2006; accepted 25 July 2006
Available online 4 August 2006
Edited by Francesc PosasAbstract Protein phosphorylation is important for regulation
of most biological functions and up to 50% of all proteins are
thought to be modiﬁed by protein kinases. Increased knowledge
about potential phosphorylation of a protein may increase our
understanding of the molecular processes in which it takes part.
Despite the importance of protein phosphorylation, identiﬁcation
of phosphoproteins and localization of phosphorylation sites is
still a major challenge in proteomics. However, high-throughput
methods for identiﬁcation of phosphoproteins are being devel-
oped, in particular within the ﬁelds of bioinformatics and mass
spectrometry. In this review, we present a toolbox of current
technology applied in phosphoproteomics including compu-
tational prediction, chemical approaches and mass spectro-
metry-based analysis, and propose an integrated strategy for
experimental phosphoproteomics.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The cellular proteome is highly dynamic because the ex-
pressed proteins, their abundance, and their post-translational
modiﬁcations depend on the physiological state of the cell.
Phosphorylation is one of the most common and best charac-
terized post-translational modiﬁcations (PTM) of cellular pro-
teins. Activation of protein kinases and phosphatases provides
a powerful control of the phosphorylation state, and thus the
subsequent biological process e.g. through alteration of pro-
tein activity, subcellular localization, degradation, conforma-Abbreviations: ANN, artiﬁcial neural network; ESI, electrospray ion-
ization; GPS, group-based phosphorylation site predicting and scoring
platform; HPLC, high performance liquid chromatography; HPRD,
human protein reference database; IMAC, immobilized metal aﬃnity
chromatography; LC-MS/MS, liquid chromatography tandem mass
spectrometry; MALDI-TOF, matrix-assisted laser desorption ioniza-
tion time-of-ﬂight; PTM, post-translational modiﬁcation; QTOF,
quadrupole time-of-ﬂight; SDS–PAGE, sodium dodecyl sulphate–po-
lyacrylamide gel electrophoresis; SILAC, stable isotope labelling by
amino acid in cell culture; siRNA, small interfering RNA; SVM, su-
pport vector machine
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doi:10.1016/j.febslet.2006.07.068tion, or interaction with other proteins. Regulation of the
cell cycle, membrane transport and permeability, cell adhesion,
neurotransmission, and metabolism are examples of biological
functions that are modulated through protein phosphorylation
[1]. The human genome contains 518 diﬀerent protein kinases
and identiﬁcation of their biological targets is an active re-
search area [2]. Even though the number of identiﬁed phospho-
proteins is rapidly increasing especially due to development of
high-throughput methods for the identiﬁcation of phospho-
proteins, in particular within the ﬁelds of bioinformatics and
mass spectrometry, it is believed that only a small fraction of
physiological phosphorylation sites has been assigned. In this
review a toolbox of techniques currently available for analysis
of the phosphoproteome is presented (Fig. 1). Based on this
overview we propose an integrated strategy for high-through-
put analysis of phosphorylated proteins (Fig. 2).2. Computational phosphoproteomics
The speciﬁcity of protein kinases is determined by e.g. acidic,
basic, or hydrophobic amino acids adjacent to the phosphoac-
ceptor site often referred to as the consensus sequence of the
kinase. Alternatively, a key determinant for MAP kinase and
CDK speciﬁcity is a proline in the +1 position. A wide range
of computational approaches have been developed for predic-
tions of phosphorylation sites ranging from simple motif
searches to more complex methods like the artiﬁcial neural net-
works (ANN) where sequence correlations can be taken into
account (Table 1).
Deﬁnition of sequence motifs for speciﬁc kinases have, for
example, been included in the PROSITE database [3]. The
drawback of this simple motif search is that the consensus se-
quence often is based on limited data and that the sensitivity of
this approach tend to be quite low [4]. Another simple ap-
proach is the group-based phosphorylation scoring (GPS)
method, which is based on comparison of the sequence sur-
rounding the reported phosphorylation sites (three residues
on each side of the site) to a given heptapeptide in the candi-
date substrate. This approach has recently been used for
prediction of phosphorylation sites for 71 protein kinase sub-
families [5].
A more complex method for prediction of phosphorylation
sites is based on weight matrices which deﬁnes more diverse
patterns and makes it possible to rank the predicted phosphor-
ylation sites. Scansite is a weight matrix-based kinase-speciﬁc
phosphorylation sites prediction server containing more thanblished by Elsevier B.V. All rights reserved.
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Fig. 1. Techniques currently used for phosphoproteome analysis including computational biology, protein chemistry, and mass spectrometry-based
analysis.
4b. Sequencing by tandem mass spectrometry 
(MS/MS), hypothesis-driven MS/MS 
1. Computational prediction of kinase substrates and phosphorylation sites
2. Phosphorylation in vitro or in vivo of proteins by active kinases (e.g. radiolabelling)
3a. Gel electrophoresis, 2D 
phosphopeptide mapping, autoradiography 
SIX STEPS IN EXPERIMENTAL PHOSPHOPROTEOMICS
6. Functional characterization of phosphoprotein and phosphorylation sites in vitro and in vivo 
5. Validation by immunochemistry, site-directed mutagenesis, kinase inhibitors, siRNA
3b.Phosphopeptide enrichment by IMAC or 
titanium dioxide chromatography 
4a. Sequencing by Edman degradation, 
phosphoamino acid analysis 
Fig. 2. Strategies for integrated analysis of phosphoproteins using computational biology, protein chemistry, and mass spectrometry.
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many families of Ser/Thr- or Tyr-kinases, SH2, SH3, PDZ,
14-3-3 and PTB domains [6]. The prediction of phosphoryla-
tion sites by Scansite is based on in vitro phosphorylation of
an oriented peptide library by speciﬁc protein kinases [7]. A
major advantage of this approach is that the sequence motifs
are determined in unbiased experiments and that no prior
knowledge of substrates is required. One limitation is that
the optimal sequence might not be determined, since ﬁveamino acids have been omitted during synthesis of the
peptide library. Secondly, the synthetic peptide includes only
eight amino acid residues around the site of phosphorylation
and neglects the role of more distant residues for speciﬁcity.
Finally, synergy between amino acids in two or more positions
in the motif will be underestimated by this approach.
Sequence motifs are complex in the sense that positional cor-
relation between several residues is signiﬁcant for the speciﬁc-
ity. Hence, complex machine learning approaches such as
Table 1
WWW-accessible phosphorylation site prediction servers and databases
WWW-accessibility
Phosphorylation site prediction servers
GPS http://973-proteinweb.ustc.edu.cn/gps/gps_web/
KinasePhos http://KinasePhos.mbc.nctu.edu.tw/
NetPhos www.cbs.dtu.dk/services/NetPhos/
NetPhosK www.cbs.dtu.dk/services/NetPhosK/
PredPhospho www.ngri.re.kr/proteo/PredPhospho.htm/
PREDIKIN http://ﬂorey.biosci.uq.edu.au/kinsub/home.htm
Prosite http://us.expasy.org/prosite/
Scansite http://scansite.mit.edu
Phosphorylation site databases
PhosphoBase http://www.cbs.dtu.dk/databases/PhosphoBase/
Phospho.ELM http://phospho.elm.eu.org/
Human protein reference database (HPRD) http://www.hprd.org/
PhosphoSite http://www.phosphosite.org/
Swiss-Prot http://us.expasy.org/sprot/
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tion of phosphorylation sites. ANN is capable of classifying
highly complex and nonlinear biological sequence patterns,
where correlations between positions are important [8]. ANN
has been extensively used in biological sequence analysis, be-
cause they do not only recognize patterns seen during training
but also retain the ability to generalize and recognize similar
patterns [9]. Originally, the ANN-based algorithm NetPhos,
was developed for prediction of the general phosphorylation
status using experimentally validated Ser, Thr, and Tyr phos-
phorylation sites in the curated database PhosphoBase [4,10].
Recently, a kinase-speciﬁc version, termed NetPhosK, was
developed for prediction of phosphorylation sites for 17 pro-
tein kinases [11,12]. The false-negative and false-positive pre-
dictions of the PKA-speciﬁc neural network was determined
experimentally to 0% and 59%, corresponding to a sensitivity
and speciﬁcity of 100% and 41%, respectively [12].
In addition, Kim et al. have used support vector machines
(SVM), which are classes of ANN, for prediction of phosphor-
ylation sites at both the kinase family and group level. This
prediction server, PredPhospho, is available for four kinase
families (CDK, CK2, PKA and PKC) and four kinase groups
(AGC, CAMK, CMGC and TK) [13]. Recently, SVMs were
also applied for prediction of PKA, PKC, CK, CK2 and
CDC2 kinase phosphorylation sites by Plewczynski et al.
[14]. KinasePhos based on proﬁle hidden Markov model is an-
other tool for prediction of kinase-speciﬁc phosphorylation
sites [15]. Finally, a diﬀerent approach termed PREDIKIN
has been developed for prediction of kinase speciﬁcity. PRED-
IKIN predicts optimal substrate heptapeptides by analysis of
the primary sequence of the catalytic domain of the protein ki-
nase [16]. One advantage of the PREDIKIN approach is that it
can predict phosphorylation sites for uncharacterized kinases
for which no information other than the amino acid sequence
is available. Recently, an algorithm was designed to extract
phosphorylation motifs from large mass spectrometry data sets
of phosphorylated proteins [17]. The method relies on the
intrinsic alignment of phospho-residues and the extraction of
motifs through iterative comparison to a dynamic statistical
background. The method was able to predict dozens of novel
and known phosphorylation sites from published Ser, Thr
and Tyr phosphorylation studies.
In conclusion, computational prediction methods have sev-
eral advantages in phosphoproteomics. First, they are fastand reproducible, and are publicly available at web servers.
Second, they have proven to be suﬃciently accurate for opti-
mizing experimental design [18]. Examples are that Scansite
predictions resulted in identiﬁcation of tuberin as a PKB sub-
strate linking PI3K to tuberous sclerosis [19] as well as identi-
ﬁcation and characterization of novel PKA substrates [12,20].
On the other hand, computational approaches also have limi-
tations. Computational prediction servers are based on exper-
imental data and the accuracy of the predictions is strongly
dependent on the quality of the data. The amount of data re-
quired for development of a high quality prediction method
depends on the diversity of the acceptor motif of the kinase.
In addition, it is not obvious how well a particular algorithm
based on a limited data set can predict phosphorylation sites
in the sequence space. Kinase speciﬁcity is also aﬀected by
other factors than the amino acid sequence of the substrates
including co-localization of the kinase and its substrate, sur-
face accessibility, spatial conﬁguration and kinase-docking
sites. It should always be borne in mind that computational
predictions of phosphorylation sites are based solely on se-
quence comparison and predicted sites must be experimentally
veriﬁed before considered valid. Another caveat is that the
above mentioned bioinformatics programs are developed for
prediction of mammalian phosphorylation sites. Hence, the
predictions may fail or have higher false-negative and false-po-
sitive rates when employed in other organisms such as fungi
and plants.
Because the number of experimentally characterized phos-
phorylation sites grows tremendously another important
aspect of bioinformatics is creation of public phosphorylation
site containing databases. PhosphoBase [10], Phospho.ELM
[21], PhosphoSite [22], the human protein reference database
[23], and Swiss-Prot [24] are examples where entries are com-
piled and curated from the literature as well as from diﬀerent
protein sequence databases (Table 1).3. Classical protein chemistry and biochemistry approaches in
phosphoprotein analysis
A range of techniques has been applied in chemical and bio-
chemical analysis of phosphoproteins (Fig. 1). A classic strat-
egy for detection of phosphoproteins is radioactive labelling
in vivo with [32P]orthophosphate or in vitro using puriﬁed ki-
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[25]. However, if the protein is phosphorylated in vivo at low
stoichiometry or on multiple sites by diﬀerent protein kinases
it can be diﬃcult to isolate suﬃcient phosphorylated protein.
Hence, many protein phosphorylation studies are performed
with proteins modiﬁed in vitro. 32P-labeled phosphoproteins
can be analyzed by proteolytic digestion and separation of
peptides by two-dimensional electrophoresis. Phosphopeptides
are detected by autoradiography and the relative stoichiometry
of phosphorylation among the phosphopeptides can be deter-
mined. Phosphopeptides can be puriﬁed and phosphorylation
sites identiﬁed by N-terminal peptide sequencing using Edman
degradation. Recently, mass spectrometry has been introduced
successfully for identiﬁcation of phosphorylation sites (see be-
low). The phosphoamino acid content of phosphoproteins can
be determined by electrophoresis of 32P-labeled phosphoamino
acids together with phosphoamino acid standards followed by
autoradiography and ninhydrin staining [26,27]. The localiza-
tion of phosphorylation sites in peptides or proteins can be
determined by N-terminal sequencing of phosphopeptides
using Edman degradation. The phosphoprotein is ﬁrst enzy-
matically digested and radioactive peptides are isolated by
reverse phase high performance liquid chromatography
(RP-HPLC) [28,29]. A disadvantage of RP-HPLC is that very
hydrophilic phosphopeptides may elute in the ﬂow-through
and very hydrophobic peptides may not elute at all.
Biochemical approaches include mutation of the suspected
phosphorylation residues to alanine or phenylalanine followed
by phosphorylation assay and two-dimensional phosphopep-
tide mapping [27]. Immunochemistry using phospho-speciﬁc
antibodies is also widely used for identiﬁcation of phosphopro-
teins [30,31]. However, the speciﬁcity of some commercially
available phospho-speciﬁc antibodies has not been adequately
tested. Because phospho-speciﬁc antibodies frequently cross-
react with other phosphorylation sites on a protein, it is essen-
tial to demonstrate that mutation of the phosphorylated
residue abolishes recognition of the protein by the antibody.
This type of cross-reactivity resulted for example in misidenti-
ﬁcation of Ser112 in Bad as a PKA phosphorylation site
[32,33]. In addition, protein kinase inhibitors may be used to
identify substrates of a speciﬁc kinase. However, many kinase
inhibitors targets more than one kinase like for example the
PKA inhibitor H89, which also is a potent inhibitor of
MSK1, S6 kinase-1 and Rho-dependent kinase II [34]. Re-
cently, small interfering RNA (siRNA) have been applied
in vivo for validation of substrate phosphorylation by a se-
lected protein kinase [35].
In conclusion, classical protein chemistry and biochemical
analyses are fundamental and commonly used in phosphopro-
teome analysis. The disadvantage of these techniques is that
radioactive labelling is often required and that high amounts
of protein are needed. In addition, they are labour intensive
and cannot be used for high-throughput analysis of the phos-
phoproteome.4. Mass spectrometry analysis of phosphoproteome
Mass spectrometry-based methods, including matrix-
assisted laser desorption ionization time-of-ﬂight (MALDI-
TOF) mass spectrometry and electrospray ionizationquadrupole time-of-ﬂight (ESI-QTOF) analysis, are well estab-
lished techniques in phosphoproteomics. Characterization of
phosphoproteins by mass spectrometry requires four basic
steps including isolation of the phosphoproteins e.g. immuno-
precipitation followed by sodium dodecyl sulphate–polyacryl-
amide gel electrophoresis (SDS–PAGE), enzymatic digestion
of the protein with a protease such as trypsin, identiﬁcation
of phosphopeptides, and sequencing of the phosphopeptide
to localize phosphorylation sites [36]. Although mass spec-
trometry-based analysis of phosphoproteins sounds simple, it
is still a major challenge in proteomic research for a number
of reasons. First, identiﬁcation of phosphorylation sites re-
quires isolation and analysis of the peptide that contains the
modiﬁed residue. Furthermore, ion signals corresponding to
phosphorylated peptides are signiﬁcantly suppressed in the
presence of non-phosphorylated peptides. In addition, phos-
phorylation can inhibit the tryptic digestion of the protein
depending on the position of the phosphorylated residue rela-
tive to the tryptic cleavage site at arginine or lysine. Finally, if
proteins are phosphorylated at low stoichiometry, the detec-
tion of the phosphopeptide is diﬃcult.
Complete characterization of the primary sequence and
PTM of a protein requires much more material than mass
spectrometry sequencing of a few peptides. At least Coomas-
sie-stainable amounts (several picomoles 1 lg) should be
puriﬁed to increase the chance of identiﬁcation of phosphory-
lation sites. In addition, any puriﬁcation step that enriches for
phosphopeptides will provide better detection of phosphoryla-
tion sites. Phosphoproteins can be enriched from crude
samples by aﬃnity-based puriﬁcation including immunopre-
cipitation with phospho-speciﬁc antibodies [31]. Anti-pTyr
antibodies are used successfully for immunoprecipitation of
phosphoproteins prior to mass spectrometry analysis [37,38],
and recently also good anti-pSer and anti-pThr antibodies
have been developed [31,39]. Furthermore, immobilized metal
aﬃnity chromatography (IMAC) using Fe3+ and Ga3 is widely
used for enrichment of phosphoproteins or -peptides prior to
mass spectrometry analysis [40,41]. Some IMAC protocols re-
sult in problems with non-speciﬁc binding of non-phosphory-
lated acidic peptides. Hence, blocking the acidic residues by
O-methyl esteriﬁcation has been shown to enhance the speciﬁc-
ity of the phosphopeptide binding [42]. Recently, titanium
dioxide chromatography has also been applied for enrichment
of phosphopeptides [43]. In addition, graphite columns has
been shown to capture hydrophilic peptides such as phospho-
peptides and glycopeptides [44]. Furthermore, chromato-
graphic separation of phosphopeptides prior to mass
spectrometry has been applied to facilitate identiﬁcation of
phosphorylation sites. Liquid chromatography (LC) using
nano-columns with reversed-phase C18 material coupled di-
rectly to an ESI-QTOF tandem mass spectrometry (MS/MS)
is a successful procedure for identiﬁcation of PTM in a high-
throughput fashion [45].
Detection of phosphopeptides is often based on fragmenta-
tion of the phosphoester bonds in p-Ser, p-Thr, or p-Tyr.
Particularly beta-elimination of phosphoric acid from p-Ser
or p-Thr, lead to identiﬁcation of phosphopeptides in mass
spectra [46,47]. In addition, p-Tyr-containing peptides can spe-
ciﬁcally be detected by the production of immonium ion from
the p-Tyr residues [48]. Enzymatic dephosphorylation of the
digested peptide by protein phosphatases has also been applied
for identiﬁcation of phosphopeptides [49]. Typically, the
4768 M. Hjerrild, S. Gammeltoft / FEBS Letters 580 (2006) 4764–4770masses of the dephosphorylated peptides after phosphatase
treatment are compared to an untreated control by MALDI-
TOF analysis. Furthermore, chemical techniques for conver-
sion of phosphoamino acids into more tractable species have
been developed. Aﬃnity tags like biotin are speciﬁcally cou-
pled to the phosphopeptide by beta-elimination of phosphoric
acid from p-Ser or p-Thr followed by phosphopeptide enrich-
ment using aﬃnity chromatography [50]. Another chemical ap-
proach uses beta-elimination followed by addition of
cysteamine to convert p-Ser and p-Thr to lysine analogues
resulting in phosphoamino acid speciﬁc cleavage for trypsin
[51]. However, the chemical techniques based on beta-elimina-
tion are only applicable for p-Ser and p-Thr analysis. Another
chemical approach based on phosphoramidate chemistry en-
ables analysis of p-Ser, p-Thr as well as p-Tyr [52]. The major
disadvantage of the chemical techniques described above is
that a large amount of sample is required.
In addition to identiﬁcation of phosphoproteins and map-
ping of phosphorylation sites there is also a need for quantita-
tive analysis of phosphorylated proteins. Recently, mass
spectrometry-based techniques for relative quantiﬁcation of
PTMs has been developed using comparison with the intensity
of chemically similar peptides. These techniques include diﬀer-
ential stable isotope incorporation in proteins by metabolic
labelling in vivo or chemical labelling in vitro. Ong et al. have
designed a technique for in vivo labelling termed stable isotope
labelling by amino acid in cell culture (SILAC), where they use
amino acids containing a stable isotope [53]. In vitro labeling
with iTRAQ reagent has also been applied successfully in
quantitative phosphoproteomics [54]. An alternative to label-
ling of phosphopeptides is to run two samples separately with
a chemically synthesized heavier version of the phosphopep-
tide as an internal standard [55].5. Integrated strategy in experimental phosphoproteomics
No single high-throughput method is available for phospho-
proteome analysis. Integration of analytical techniques includ-
ing computational prediction, protein chemistry, and mass
spectrometry can facilitate detailed characterization of phos-
phoproteins. Recently, high-throughput strategies for the
identiﬁcation of phosphoproteins have been developed, in par-
ticular within the ﬁelds of bioinformatics and mass spectrom-
etry. We propose an integrated strategy for experimental
analysis of the phosphoproteome. This includes six consecutive
steps: prediction, phosphorylation, separation, identiﬁcation,
validation, and functional characterization of the phosphory-
lated protein (Fig. 2). The ﬁrst step is computational analysis
of the proteome/genome for prediction of protein kinase sub-
strates and phosphorylation sites for a given kinase or group
of kinases. Although the rate of false-positive and false-nega-
tive predictions is generally high, they may be useful to select
potential kinase substrates for further analysis. The second
step is phosphorylation in vitro or in vivo by activated kinases,
which is followed by the third step of chromatographic separa-
tion and enrichment of phosphorylated proteins or peptides. In
the fourth step phosphoproteins or peptides are sequenced
either by classical protein chemistry or by tandem mass spec-
trometry. Today, mass spectrometry is often the analytical
method of choice because of developments in diﬀerent massspectrometry-based approaches for high-throughput qualita-
tive and quantitative characterization of phosphoproteins.
However, one major limitation of mass spectrometry is that
the sequence coverage never is 100% especially when complex
sample mixtures are analysed. One way to improve the mass
spectrometry analysis can be aﬃnity-based enrichment of
phosphopeptides, e.g., by IMAC or titanium dioxide chroma-
tography. Alternatively, it can be an advantage to use compu-
tational prediction of phosphopeptides for targeted selection
of peptides for sequencing in tandem mass spectrometry. The
ﬁfth step involves validation of phosphorylation sites using
phospho-speciﬁc antibodies, mutation of phosphorylated resi-
dues, kinase inhibitors, and siRNA. Finally, functional evalu-
ation of the identiﬁed phosphorylation sites requires detailed
studies in vitro and in vivo. These techniques have been ap-
plied for characterization of phosphorylation sites for decades,
but the drawback is that high-throughput analysis of phospho-
proteins is not possible.
This integrated strategy is limited to characterization of ki-
nase-substrate pairs for well characterized mammalian protein
kinases since the prediction programs are based on known
phosphorylation motifs that are determined to yield a fairly ro-
bust deﬁnition of speciﬁcity. However, this level of knowledge
exists for only about 10% of the 518 human protein kinases.
Consequently, the prediction aspect of the ﬁrst step of the inte-
grated strategy does not function without a priori knowledge
of a kinase target. Moreover, the recent technical development
related to mass spectrometry has lead to generation of vast
amounts of empirical data in phosphoproteomics. Hence, an
alternative strategy would be to begin with the large datasets
and then use bioinformatics to sort the mass spectrometry data
[17]. This means that empirically determined phosphorylation
sites are used for the predicting kinases substrates de novo in
contrast to predicting new substrates for known kinases as out-
lined above. For instance, taking a rough MAP kinase consen-
sus of Ser/Thr-Pro presents a tremendous false-negative
population. Further reﬁnement to an ’improved’ consensus
of Pro-X-Ser/Thr-Pro decreases the false-negative rate, but still
includes a great deal of noise. If one begins with empirically
determined pSer/pThr-Pro sequences from mass spectrometry
phosphoproteomics, this step would greatly decrease the
amount of experimental validation required for each kinase.
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